Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis
Sponsor: Laboratoires Thea
Summary
The aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis
Official title: Efficacy and Safety Assessment of T1695 Ophthalmic Suspension, Versus Ciclosporin Ophthalmic Emulsion, in Participants With Moderate to Severe Vernal Keratoconjunctivitis (VKC).
Key Details
Gender
All
Age Range
4 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-03-02
Completion Date
2027-01-21
Last Updated
2025-09-12
Healthy Volunteers
No
Interventions
Slit Lamp Examination
The participant will have a slit lamp examination
Far Best Corrected Visual Acuity (BCVA)
The participant 's BCVA will be evaluated.
T1695
The participant should instill T1695.
Ciclosporin
The participant should instill Ciclosporin.
Corneal fluorescein staining score on modified Oxford scale
One drop of fluorescein will be instilled to assess the fluorescein staining score on the modified Oxford scale.